Theriva Biologics (TOVX) Q2 2026 Earnings

5MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-4.19
-2.81
-1.43
-0.05

Details

Expected EPS
-0.05
Actual EPS
-0.05
Surprise EPS
0
Surprise Percent
+0%

Description

Theriva Biologics (TOVX) has reported earnings of -0.05 per share for Q2 2026.

0 Comments

Share your thoughts